Skip to content

Patients' Knowledge and Understanding of Cancer Clinical Trials - a Study of Audio Recorded Information

Patients' Knowledge and Understanding of Cancer Clinical Trials - a Randomised Study of Audio Recorded Information

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01502254
Enrollment
130
Registered
2011-12-30
Start date
2008-10-31
Completion date
2013-01-31
Last updated
2014-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Informed consent, Cancer clinical trials, Patient information, Knowledge, Questionnaire, Patient Eligible for a Phase II or III Cancer Clinical Trial, Scheduled Clinical Visit for Information About a Trial

Brief summary

The purpose of this study is to test if cancer patients who are informed about, and offered participation in a cancer clinical trial, are more knowledgeable about cancer clinical trials if they have access to an audio recording of their information visit.

Interventions

OTHERaudio recorded information

Access to the audio recorded information about the clinical trial the patient was information about and asked to consider. A copy of the audio recording is given to the patients directly after the clinical visit.

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed in Swedish about a phase II or III clinical trial * Signed a consent form

Design outcomes

Primary

MeasureTime frameDescription
Patients' knowledge about clinical trials measured by the questionnaire Quality of Informed ConsentThe questionnaire is sent to patients within a week after consenting to the trial.The questionnaire is sent to patients within a week after consenting to the trial. One reminder is sent to those not responding within two weeks.

Secondary

MeasureTime frameDescription
Patients' perceived understanding of clinical trials measured by the questionnaire Quality of Informed ConsentThe questionnaire is sent to patients within a week after consenting to the trial.The questionnaire is sent to patients within a week after consenting to the trial. One reminder is sent to those not responding within two weeks.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026